Все публикации

0:00:56

“How does PRIMR’s educational approach help accelerate clinical trial enrollment?”

0:00:55

I have aggressive #prostatecancer—how can IRE pulses in the RTIRE trial reduce my side effects?

0:00:55

'I have recurrent #prostatecancer—how can INDICATE help personalize my treatment with PET scans?'

0:01:00

'I have #prostatecancer—how can PSMA PET/CT improve active surveillance accuracy?”

0:00:59

“I have lung cancer but I can't have surgery—what should I know about radiation treatments?”

0:00:59

”I have prostate cancer—how can PET scan-guided treatment in the INDICATE trial improve outcomes?”

0:03:26

Prostate Cancer Clinical Trial: INDICATE (Part 1 of 3)

0:02:23

Prostate Cancer Clinical Trial: INDICATE (Part 2 of 3)

0:03:11

Prostate Cancer Clinical Trial: INDICATE (Part 3 of 3)

0:00:52

'I have oligometastatic prostate cancer—can targeted RT + standard treatment delay cancer growth?'

0:00:48

“I have #lungcancer—what are my surgical options, and how do I know if I qualify?'

0:00:56

“I have kidney cancer—how can immunotherapy help if I’m not eligible for surgery?”

0:00:53

'I have lymph node-positive lung cancer—why is chemoradiation better than surgery in my case?'

0:00:53

“I have prostate cancer—how can adding apalutamide to standard treatment improve my outcomes?”

0:00:47

RADICALS 04 Radium 223 Animation

0:00:47

”I have kidney cancer with bone mets—how can adding Ra-223 to cabozantinib improve my outcomes?”

0:00:35

'I have myelofibrosis—how can understanding diagnosis, risks, and treatment options help me?”

0:00:59

”I have myelofibrosis—how can I simplify understanding my condition?”

0:02:31

New Myelofibrosis Diagnosis - What to Expect

0:02:31

New Myelofibrosis Diagnosis - What to Expect

0:01:01

Gynecologic Cancer - What Organs are Impacted?

0:00:59

“I have lung cancer—how do lung anatomy basics help me understand my treatment options?”

0:00:58

”I'm a prostate cancer patient—how can electric pulses from IRE improve my cancer treatment?”

0:01:00

'I have kidney cancer—how do factors like tumor size and location affect my treatment options?”